Skip to main content
Erschienen in: Tumor Biology 3/2013

01.06.2013 | Review

Colorectal cancer: a researcher’s perspective of the molecular angel’s gone eccentric in the Vale of Kashmir

verfasst von: Aga Syed Sameer

Erschienen in: Tumor Biology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Colorectal cancer (CRC), being the most common cancer, is the major cause of mortality and morbidity worldwide. In Kashmir, CRC has been found to be the third most common gastrointestinal cancer after esophageal and gastric. The etiology of CRC involves two pathways: chromosomal instability (CIN) and microsatellite instability. CIN occurs in 80–85 % of CRC resulting in either gross changes in chromosome structure and number or point mutations in the chromosomes. Many molecular studies have been carried out on CRC in Kashmir so as to elucidate the role of tumor suppressor genes and oncogenes in modulating the carcinogenesis. We searched the various literature databases including Medline, PubMed, ASCO abstracts, and ESMO abstracts for the papers regarding colorectal cancer published in English using the terms “Kashmir,” “colorectal cancer,” “colon cancer,” “rectal cancer,” “carcinogenesis,” “epidemiology,” “genetics,” “mutation,” and “polymorphism.” Here in this review, I have shed light on the different studies carried on CRC in our Kashmiri population in an attempt to share what we know so far about the molecular carcinogenesis of CRC in Kashmir.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. CA. Cancer J Clin 2011; 61(2): 69–90. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. CA. Cancer J Clin 2011; 61(2): 69–90.
3.
4.
Zurück zum Zitat O'brien MJ, Winawer SJ, Zauber AG, Bushey MT, Sternberg SS, Gottlieb LS, et al. Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol. 2004;2:905–11.PubMedCrossRef O'brien MJ, Winawer SJ, Zauber AG, Bushey MT, Sternberg SS, Gottlieb LS, et al. Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol. 2004;2:905–11.PubMedCrossRef
5.
Zurück zum Zitat Zauber AG, O'Brien MJ, Winawer SJ. On finding flat adenomas: is the search worth the gain? Gastroenterology. 2002;122:839–40.PubMedCrossRef Zauber AG, O'Brien MJ, Winawer SJ. On finding flat adenomas: is the search worth the gain? Gastroenterology. 2002;122:839–40.PubMedCrossRef
6.
Zurück zum Zitat Paula MC, Harold F. The genetics of CRC. Ann Intern Med. 2002;137:603–12.CrossRef Paula MC, Harold F. The genetics of CRC. Ann Intern Med. 2002;137:603–12.CrossRef
7.
Zurück zum Zitat Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol. 1932;35:323.CrossRef Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol. 1932;35:323.CrossRef
8.
Zurück zum Zitat Hardy RG, Meltzer ST, Jankowski JA. Molecular basis for risk factors. ABC of CRC. BMJ Books. 2001;2:5–8. Hardy RG, Meltzer ST, Jankowski JA. Molecular basis for risk factors. ABC of CRC. BMJ Books. 2001;2:5–8.
9.
Zurück zum Zitat Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, Preussmann R. Increased exposure to dietary amines and nitrate in a population at high risk of esophageal and gastric cancer in Kashmir (India). Carcinogenesis. 1992;13:1331–5.PubMedCrossRef Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, Preussmann R. Increased exposure to dietary amines and nitrate in a population at high risk of esophageal and gastric cancer in Kashmir (India). Carcinogenesis. 1992;13:1331–5.PubMedCrossRef
10.
Zurück zum Zitat Mir MM, Dar NA, Gochhait S, Zargar SA, Ahangar AG, Bamezai RN. p53 Mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int J Cancer. 2005;116:62–8.PubMedCrossRef Mir MM, Dar NA, Gochhait S, Zargar SA, Ahangar AG, Bamezai RN. p53 Mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int J Cancer. 2005;116:62–8.PubMedCrossRef
11.
Zurück zum Zitat Murtaza I, Mushtaq D, Margoob MA, Dutt A, Wani NA, Ahmad I, et al. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol. 2006;12:4033–7.PubMed Murtaza I, Mushtaq D, Margoob MA, Dutt A, Wani NA, Ahmad I, et al. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol. 2006;12:4033–7.PubMed
12.
Zurück zum Zitat Salam I, Hussain S, Mir MM, Dar NA, Abdullah S, Siddiqi MA, et al. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Mol Cell Biochem. 2009;332:51–8.PubMedCrossRef Salam I, Hussain S, Mir MM, Dar NA, Abdullah S, Siddiqi MA, et al. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Mol Cell Biochem. 2009;332:51–8.PubMedCrossRef
13.
Zurück zum Zitat Sameer AS, ul Rehman S, Pandith AA, Syeed N, Shah ZA, Chowdhri NA, et al. Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J Gastroenterol. 2009;15:244–52.PubMedCrossRef Sameer AS, ul Rehman S, Pandith AA, Syeed N, Shah ZA, Chowdhri NA, et al. Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J Gastroenterol. 2009;15:244–52.PubMedCrossRef
14.
Zurück zum Zitat Sameer AS, Chowdri NA, Syeed N, Banday MZ, Shah ZA, Siddiqi MA. SMAD4–molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene. BMC Cancer. 2010;10:300.PubMedCrossRef Sameer AS, Chowdri NA, Syeed N, Banday MZ, Shah ZA, Siddiqi MA. SMAD4–molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene. BMC Cancer. 2010;10:300.PubMedCrossRef
15.
Zurück zum Zitat Shah A, Jan GM. Pattern of cancer at Srinagar (Kashmir). Indian J Pathol Microbiol. 1990;33:118–23.PubMed Shah A, Jan GM. Pattern of cancer at Srinagar (Kashmir). Indian J Pathol Microbiol. 1990;33:118–23.PubMed
16.
Zurück zum Zitat Javid G, Zargar SA, Rather S, Khan AR, Khan BA, Yattoo GN, et al. Incidence of colorectal cancer in Kashmir valley, India. Indian J Gastroenterol. 2011;30:7–11.PubMedCrossRef Javid G, Zargar SA, Rather S, Khan AR, Khan BA, Yattoo GN, et al. Incidence of colorectal cancer in Kashmir valley, India. Indian J Gastroenterol. 2011;30:7–11.PubMedCrossRef
17.
Zurück zum Zitat Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.PubMedCrossRef Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.PubMedCrossRef
18.
Zurück zum Zitat Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut. 2005;54:1283–6.PubMedCrossRef Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut. 2005;54:1283–6.PubMedCrossRef
19.
Zurück zum Zitat Esteller M, Gonzalez S, Risques RA, Marcuello E, Mangues R, Germa JR, et al. K-ras and p16 aberrations confer poor prognosis in human CRC. J Clin Oncol. 2001;19:299–304.PubMed Esteller M, Gonzalez S, Risques RA, Marcuello E, Mangues R, Germa JR, et al. K-ras and p16 aberrations confer poor prognosis in human CRC. J Clin Oncol. 2001;19:299–304.PubMed
20.
Zurück zum Zitat Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, et al. APC, K-ras, and p53 gene mutations in CRC patients: correlation to clinicopathologic features and postoperative surveillance. Am Surg. 2005;71:336–43.PubMed Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, et al. APC, K-ras, and p53 gene mutations in CRC patients: correlation to clinicopathologic features and postoperative surveillance. Am Surg. 2005;71:336–43.PubMed
21.
Zurück zum Zitat Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.PubMedCrossRef Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.PubMedCrossRef
22.
Zurück zum Zitat Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in CRC. Cancer Res. 1998;58:5248–57.PubMed Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in CRC. Cancer Res. 1998;58:5248–57.PubMed
23.
Zurück zum Zitat Benatti P, Gafa R, Barana D, Marino M, Scarselli A, Pedroni M, et al. Microsatellite instability and CRC prognosis. Clin Cancer Res. 2005;11:8332–40.PubMedCrossRef Benatti P, Gafa R, Barana D, Marino M, Scarselli A, Pedroni M, et al. Microsatellite instability and CRC prognosis. Clin Cancer Res. 2005;11:8332–40.PubMedCrossRef
24.
Zurück zum Zitat Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol. 1999;154:1805–13.PubMedCrossRef Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol. 1999;154:1805–13.PubMedCrossRef
25.
Zurück zum Zitat Kerr DJ, Young EM, Hobbs FDR. ABC of colorectal cancer. 1st ed. London: BMJ; 2001. Kerr DJ, Young EM, Hobbs FDR. ABC of colorectal cancer. 1st ed. London: BMJ; 2001.
27.
Zurück zum Zitat Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, Albertsen H. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res. 2007;5:165–70.PubMedCrossRef Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, Albertsen H. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res. 2007;5:165–70.PubMedCrossRef
28.
Zurück zum Zitat Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003;2:41.PubMedCrossRef Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003;2:41.PubMedCrossRef
29.
Zurück zum Zitat Baker SK, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinoma. Science. 1989;244:217–21.PubMedCrossRef Baker SK, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinoma. Science. 1989;244:217–21.PubMedCrossRef
30.
31.
Zurück zum Zitat Harris CC, Hollstein M. Clinical implication of the p53 tumor suppressor gene. N Engl J Med. 1993;329:1318–27.PubMedCrossRef Harris CC, Hollstein M. Clinical implication of the p53 tumor suppressor gene. N Engl J Med. 1993;329:1318–27.PubMedCrossRef
32.
Zurück zum Zitat Remvikos Y, Laurent-Puig P, Salmon RJ, Frelat G, Dutrillaux B, Thomas G. Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer. 1990;45:450–6.PubMedCrossRef Remvikos Y, Laurent-Puig P, Salmon RJ, Frelat G, Dutrillaux B, Thomas G. Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer. 1990;45:450–6.PubMedCrossRef
33.
Zurück zum Zitat Hussain I, ul Rehman S, Afroze D, Zahoor L, Abdullah S, Hafiz A, et al. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population. Mutat Res. 2009;676(1–2):5–10.PubMed Hussain I, ul Rehman S, Afroze D, Zahoor L, Abdullah S, Hafiz A, et al. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population. Mutat Res. 2009;676(1–2):5–10.PubMed
34.
Zurück zum Zitat Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer. 2001;1:233–40.PubMedCrossRef Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer. 2001;1:233–40.PubMedCrossRef
35.
Zurück zum Zitat Børresen-Dale AL, Lothe RA, Meling GI, Hainaut P, Rognum TO, Skovlund E. TP53 and long-term prognosis in colorectal cancer: mutations in the L3 Zinc-binding domain predict poor survival. Clin Cancer Res. 1998;4:203–10.PubMed Børresen-Dale AL, Lothe RA, Meling GI, Hainaut P, Rognum TO, Skovlund E. TP53 and long-term prognosis in colorectal cancer: mutations in the L3 Zinc-binding domain predict poor survival. Clin Cancer Res. 1998;4:203–10.PubMed
37.
Zurück zum Zitat Boguski M, McCormick F. Proteins regulating Ras and its relatives. Nature. 1993;366:643–53.PubMedCrossRef Boguski M, McCormick F. Proteins regulating Ras and its relatives. Nature. 1993;366:643–53.PubMedCrossRef
38.
Zurück zum Zitat Donovan S, Shannon KM, Bollag G. GTPase activating proteins: critical regulators of intracellular signaling. BBA Rev Cancer. 2002;1602:23–45. Donovan S, Shannon KM, Bollag G. GTPase activating proteins: critical regulators of intracellular signaling. BBA Rev Cancer. 2002;1602:23–45.
39.
Zurück zum Zitat Khosrave-far R, Der CJ. The ras signal transduction pathway. Cancer Metastasis Rev. 1994;13:67–89.CrossRef Khosrave-far R, Der CJ. The ras signal transduction pathway. Cancer Metastasis Rev. 1994;13:67–89.CrossRef
40.
Zurück zum Zitat Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7:295–308.PubMedCrossRef Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7:295–308.PubMedCrossRef
41.
Zurück zum Zitat Fearon ER. Molecular genetic studies of the adenoma–carcinoma sequence. Adv Intern Med. 1994;39:123–47.PubMed Fearon ER. Molecular genetic studies of the adenoma–carcinoma sequence. Adv Intern Med. 1994;39:123–47.PubMed
42.
Zurück zum Zitat Bazan V, Migliavacca M, Zanna I, Tubiolo C, Grassi N, Latteri MA, et al. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol. 2002;13:1438–46.PubMedCrossRef Bazan V, Migliavacca M, Zanna I, Tubiolo C, Grassi N, Latteri MA, et al. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol. 2002;13:1438–46.PubMedCrossRef
43.
Zurück zum Zitat Brink M, Weijenberg MP, de Goeij AF, Roemen GM, Lentjes MH, de Bruıne AP, et al. Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study. BJ Cancer. 2005;92:1310–20.CrossRef Brink M, Weijenberg MP, de Goeij AF, Roemen GM, Lentjes MH, de Bruıne AP, et al. Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study. BJ Cancer. 2005;92:1310–20.CrossRef
44.
Zurück zum Zitat Sameer AS, Chowdhri NA, Abdullah S, Shah ZA, Siddiqi MA. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report. Indian J Cancer. 2009;46:219–25.PubMedCrossRef Sameer AS, Chowdhri NA, Abdullah S, Shah ZA, Siddiqi MA. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report. Indian J Cancer. 2009;46:219–25.PubMedCrossRef
46.
Zurück zum Zitat Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.PubMedCrossRef Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.PubMedCrossRef
47.
Zurück zum Zitat Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116:855–67.PubMedCrossRef Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116:855–67.PubMedCrossRef
48.
51.
Zurück zum Zitat Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837–51.PubMed Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837–51.PubMed
52.
Zurück zum Zitat Chen J, Röcken C, Lofton-Day C, Schulz HU, Müller O, Kutzner N, et al. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis. Carcinogenesis. 2005;26:37–43.PubMedCrossRef Chen J, Röcken C, Lofton-Day C, Schulz HU, Müller O, Kutzner N, et al. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis. Carcinogenesis. 2005;26:37–43.PubMedCrossRef
53.
Zurück zum Zitat Zare M, Jazii FR, Alivand MR, Nasseri NK, Malekzadeh R, Yazdanbod M. Qualitative analysis of adenomatous polyposis coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. BMC Cancer. 2009;9:24.PubMedCrossRef Zare M, Jazii FR, Alivand MR, Nasseri NK, Malekzadeh R, Yazdanbod M. Qualitative analysis of adenomatous polyposis coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. BMC Cancer. 2009;9:24.PubMedCrossRef
54.
Zurück zum Zitat Lind GE, Thorstensen L, Løvig T, Meling GI, Hamelin R, Rognum TO, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer. 2004;3:28.PubMedCrossRef Lind GE, Thorstensen L, Løvig T, Meling GI, Hamelin R, Rognum TO, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer. 2004;3:28.PubMedCrossRef
55.
Zurück zum Zitat Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest. 2003;83:635–41.PubMed Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest. 2003;83:635–41.PubMed
56.
Zurück zum Zitat Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res. 2001;7:1998–2004.PubMed Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res. 2001;7:1998–2004.PubMed
57.
Zurück zum Zitat Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, et al. APC mutations in sporadic colorectal tumors: a mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA. 2000;97:3352–7.PubMedCrossRef Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, et al. APC mutations in sporadic colorectal tumors: a mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA. 2000;97:3352–7.PubMedCrossRef
58.
Zurück zum Zitat Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2002;196:1–7.PubMedCrossRef Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2002;196:1–7.PubMedCrossRef
59.
Zurück zum Zitat Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 2000;60:4366–71.PubMed Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 2000;60:4366–71.PubMed
60.
Zurück zum Zitat Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z, et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene. 2000;19:3642–6.PubMedCrossRef Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z, et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene. 2000;19:3642–6.PubMedCrossRef
61.
Zurück zum Zitat Arnold CN, Goel A, Niedzwiecki D, Dowell JM, Wasserman L, Compton C, et al. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. Cancer Biol Ther. 2004;3:960–4.PubMedCrossRef Arnold CN, Goel A, Niedzwiecki D, Dowell JM, Wasserman L, Compton C, et al. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. Cancer Biol Ther. 2004;3:960–4.PubMedCrossRef
62.
Zurück zum Zitat Hiltunen MO, Alhonen L, Koistinaho J, Myöhänen S, Pääkkönen M, Marin S, et al. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer. 1997;70:644–8.PubMedCrossRef Hiltunen MO, Alhonen L, Koistinaho J, Myöhänen S, Pääkkönen M, Marin S, et al. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer. 1997;70:644–8.PubMedCrossRef
63.
Zurück zum Zitat Sameer AS, Shah ZA, Abdullah S, Chowdhri NA, Siddiqi MA. Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population. Human Genom. 2011;5:441–52.CrossRef Sameer AS, Shah ZA, Abdullah S, Chowdhri NA, Siddiqi MA. Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population. Human Genom. 2011;5:441–52.CrossRef
65.
Zurück zum Zitat Behrens J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem Soc Trans. 2005;33:672–6.PubMedCrossRef Behrens J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem Soc Trans. 2005;33:672–6.PubMedCrossRef
67.
Zurück zum Zitat Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol. 2000;12:235–43.PubMedCrossRef Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol. 2000;12:235–43.PubMedCrossRef
68.
Zurück zum Zitat Attisano L, Lee-Hoeflich ST. The Smads. Genome Biol. 2001;2(3010):1–8. Attisano L, Lee-Hoeflich ST. The Smads. Genome Biol. 2001;2(3010):1–8.
69.
Zurück zum Zitat Massagué J, Blain SW, Lo RS. TGF-β signaling in growth control, cancer and heritable disorders. Cell. 2000;103:295–309.PubMedCrossRef Massagué J, Blain SW, Lo RS. TGF-β signaling in growth control, cancer and heritable disorders. Cell. 2000;103:295–309.PubMedCrossRef
71.
Zurück zum Zitat Shi Y. Structural insights on Smad function in TGF-β signaling. BioEssays. 2001;23:223–32.PubMedCrossRef Shi Y. Structural insights on Smad function in TGF-β signaling. BioEssays. 2001;23:223–32.PubMedCrossRef
72.
Zurück zum Zitat Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, et al. DPC4 gene in various tumor types. Cancer Res. 1996;56:2527–30.PubMed Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, et al. DPC4 gene in various tumor types. Cancer Res. 1996;56:2527–30.PubMed
73.
Zurück zum Zitat Woodford-Richens KL, Rowan AJ, Poulsom R, Bevan S, Salovaara R, Aaltonen LA, et al. Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers. Am J Pathol. 2001;159:1293–300.PubMedCrossRef Woodford-Richens KL, Rowan AJ, Poulsom R, Bevan S, Salovaara R, Aaltonen LA, et al. Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers. Am J Pathol. 2001;159:1293–300.PubMedCrossRef
74.
Zurück zum Zitat Roth S, Johansson M, Loukola A, Peltomaki P, Jarvinen H, Mecklin J-P, et al. Mutation analysis of SMAD2, SMAD3, and SMAD4 genes in hereditary non-polyposis CRC. J Cell Sci. 2003;11:413–9. Roth S, Johansson M, Loukola A, Peltomaki P, Jarvinen H, Mecklin J-P, et al. Mutation analysis of SMAD2, SMAD3, and SMAD4 genes in hereditary non-polyposis CRC. J Cell Sci. 2003;11:413–9.
75.
Zurück zum Zitat Hong-Tao X, Qiang W, Yang L, Lian-He Y, Shun-Dong D, Yang H, et al. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer. Ann Surg Oncol. 2007;14:3251–9.CrossRef Hong-Tao X, Qiang W, Yang L, Lian-He Y, Shun-Dong D, Yang H, et al. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer. Ann Surg Oncol. 2007;14:3251–9.CrossRef
76.
Zurück zum Zitat Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet. 2004;74:1043–50.PubMedCrossRef Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet. 2004;74:1043–50.PubMedCrossRef
77.
Zurück zum Zitat Khan NP, Pandith AA, Hussain MU, Yousuf A, Khan MS, Wani KA, et al. Novelty of Axin 2 and lack of Axin 1 gene mutation in colorectal cancer: a study in Kashmiri population. Mol Cell Biochem. 2011; 355(1-2):149-55; PMID: 21541676. Khan NP, Pandith AA, Hussain MU, Yousuf A, Khan MS, Wani KA, et al. Novelty of Axin 2 and lack of Axin 1 gene mutation in colorectal cancer: a study in Kashmiri population. Mol Cell Biochem. 2011; 355(1-2):149-55; PMID: 21541676.
78.
Zurück zum Zitat Savas S, Liu G. Studying genetic variations in cancer prognosis (and risk): a primer for clinicians. Oncologist. 2009;14:657–66.PubMedCrossRef Savas S, Liu G. Studying genetic variations in cancer prognosis (and risk): a primer for clinicians. Oncologist. 2009;14:657–66.PubMedCrossRef
79.
Zurück zum Zitat Ionita-Laza I, Rogers AJ, Lange C, Raby BA, Lee C. Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics. 2009;93:22–6.PubMedCrossRef Ionita-Laza I, Rogers AJ, Lange C, Raby BA, Lee C. Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics. 2009;93:22–6.PubMedCrossRef
80.
Zurück zum Zitat Miller RD, Phillips MS, Jo I, Donaldson MA, Studebaker JF, Addleman N, et al. High-density single-nucleotide polymorphism maps of the human genome. Genomics. 2005;86:117–26.PubMedCrossRef Miller RD, Phillips MS, Jo I, Donaldson MA, Studebaker JF, Addleman N, et al. High-density single-nucleotide polymorphism maps of the human genome. Genomics. 2005;86:117–26.PubMedCrossRef
81.
Zurück zum Zitat Rasool S, Ganai BA, Kadla SA, Ahanger AG, Qazi F, Khan T, et al. The ECRG1 290Arg/Gln polymorphism is related to risk of esophageal squamous cell carcinoma in Kashmir. Asian Pac J Cancer Prev. 2011;12:265–9.PubMed Rasool S, Ganai BA, Kadla SA, Ahanger AG, Qazi F, Khan T, et al. The ECRG1 290Arg/Gln polymorphism is related to risk of esophageal squamous cell carcinoma in Kashmir. Asian Pac J Cancer Prev. 2011;12:265–9.PubMed
82.
Zurück zum Zitat Malik MA, Zargar SA, Mittal B. Role of the metalloproteinase-7 (181A > G) polymorphism in gastric cancer susceptibility: a case control study in Kashmir Valley. Asian Pac J Cancer Prev. 2011;12:73–6.PubMed Malik MA, Zargar SA, Mittal B. Role of the metalloproteinase-7 (181A > G) polymorphism in gastric cancer susceptibility: a case control study in Kashmir Valley. Asian Pac J Cancer Prev. 2011;12:73–6.PubMed
83.
Zurück zum Zitat Malik MA, Sharma K, Goel S, Zargar SA, Mittal B. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley. Oncol Res. 2011;19:165–9.PubMedCrossRef Malik MA, Sharma K, Goel S, Zargar SA, Mittal B. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley. Oncol Res. 2011;19:165–9.PubMedCrossRef
84.
Zurück zum Zitat Malik MA, Zargar SA, Mittal B. Role of NQO1 609C > T and NQO2-3423 G > A polymorphisms in susceptibility to gastric cancer in Kashmir Valley. DNA Cell Biol. 2011;30:297–303.PubMedCrossRef Malik MA, Zargar SA, Mittal B. Role of NQO1 609C > T and NQO2-3423 G > A polymorphisms in susceptibility to gastric cancer in Kashmir Valley. DNA Cell Biol. 2011;30:297–303.PubMedCrossRef
85.
Zurück zum Zitat Hussain SMY, Thakur N, Salam I, Singh N, Mir MM, Bhat MA, et al. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley—a high risk area. Mol Carcinog. 2011. doi:10.1002/mc.20732. Hussain SMY, Thakur N, Salam I, Singh N, Mir MM, Bhat MA, et al. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley—a high risk area. Mol Carcinog. 2011. doi:10.​1002/​mc.​20732.
86.
Zurück zum Zitat Pandith AA, Khan NP, Shah ZA, Shah AM, Wani SM, Siddiqi MA. Association of bladder cancer risk with an NAD(P)H: quinone oxidoreductase polymorphism in an ethnic Kashmiri population. Biochem Genet 2011; 49(7-8):417-26; PMID: 21253823. Pandith AA, Khan NP, Shah ZA, Shah AM, Wani SM, Siddiqi MA. Association of bladder cancer risk with an NAD(P)H: quinone oxidoreductase polymorphism in an ethnic Kashmiri population. Biochem Genet 2011; 49(7-8):417-26; PMID: 21253823.
87.
Zurück zum Zitat Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, et al. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet Cytogenet. 2010;203:263–8.PubMedCrossRef Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, et al. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet Cytogenet. 2010;203:263–8.PubMedCrossRef
88.
Zurück zum Zitat Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer. 2010;62:734–42.PubMedCrossRef Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer. 2010;62:734–42.PubMedCrossRef
89.
Zurück zum Zitat Shaffi SM, Shah MA, Bhat IA, Koul P, Ahmad SN, Siddiqi MA. CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population. Asian Pac J Cancer Prev. 2009;10:651–6.PubMed Shaffi SM, Shah MA, Bhat IA, Koul P, Ahmad SN, Siddiqi MA. CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population. Asian Pac J Cancer Prev. 2009;10:651–6.PubMed
90.
Zurück zum Zitat Sameer AS, Shah ZA, Syeed N, Banday MZ, Bashir SM, Bhat BA, et al. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population. Genet Mol Res. 2010;9:651–60.PubMedCrossRef Sameer AS, Shah ZA, Syeed N, Banday MZ, Bashir SM, Bhat BA, et al. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population. Genet Mol Res. 2010;9:651–60.PubMedCrossRef
91.
Zurück zum Zitat Sameer AS, Shah ZA, Syeed N, Rasool R, Afroze D, Siddiqi MA. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev. 2010;11:209–13.PubMed Sameer AS, Shah ZA, Syeed N, Rasool R, Afroze D, Siddiqi MA. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev. 2010;11:209–13.PubMed
92.
Zurück zum Zitat Sameer AS, Nissar S, Qadri Q, Alam S, Baba SM, Siddiqi MA. Role of CYP2E1 genotypes in susceptibility to colorectal cancer in Kashmiri population. Hum Genomics 2011; 5(6):530-7. Sameer AS, Nissar S, Qadri Q, Alam S, Baba SM, Siddiqi MA. Role of CYP2E1 genotypes in susceptibility to colorectal cancer in Kashmiri population. Hum Genomics 2011; 5(6):530-7.
93.
Zurück zum Zitat Sameer AS, Nissar S, Syed M, Siddiqi MA. MTHFR C677T polymorphism and colorectal cancer predisposition in Kashmiri population. Genet Mol Res. 2011;10:1200–10.PubMedCrossRef Sameer AS, Nissar S, Syed M, Siddiqi MA. MTHFR C677T polymorphism and colorectal cancer predisposition in Kashmiri population. Genet Mol Res. 2011;10:1200–10.PubMedCrossRef
94.
Zurück zum Zitat Whibley C, Pharoah PDP, Hollstein M. p53 Polymorphisms: cancer implications. Nat Rev Cancer. 2009;9:95–107.PubMedCrossRef Whibley C, Pharoah PDP, Hollstein M. p53 Polymorphisms: cancer implications. Nat Rev Cancer. 2009;9:95–107.PubMedCrossRef
95.
Zurück zum Zitat Bojesen SE, Nordestgaard BG. The common germline Arg72Pro polymorphism of p53 and increased longevity in humans. Cell Cycle. 2008;7:158–63.PubMedCrossRef Bojesen SE, Nordestgaard BG. The common germline Arg72Pro polymorphism of p53 and increased longevity in humans. Cell Cycle. 2008;7:158–63.PubMedCrossRef
96.
Zurück zum Zitat Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, et al. Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer. 2008;8:32.PubMedCrossRef Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, et al. Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer. 2008;8:32.PubMedCrossRef
97.
98.
Zurück zum Zitat Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene. 2006;25:1602–11.PubMedCrossRef Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene. 2006;25:1602–11.PubMedCrossRef
99.
Zurück zum Zitat Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092–100.PubMed Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092–100.PubMed
100.
Zurück zum Zitat Dumont P, Leu JI, Della Pietra 3rd AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.PubMedCrossRef Dumont P, Leu JI, Della Pietra 3rd AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.PubMedCrossRef
101.
Zurück zum Zitat Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol. 2004;6:443–50.PubMedCrossRef Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol. 2004;6:443–50.PubMedCrossRef
102.
Zurück zum Zitat Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47–54.PubMedCrossRef Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47–54.PubMedCrossRef
103.
Zurück zum Zitat Ignaszak-Szczepaniak M, Horst-Sikorska W, Sawicka J, Kaczmarek M, Slomski R. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients. Oncol Rep. 2006;16:65–71.PubMed Ignaszak-Szczepaniak M, Horst-Sikorska W, Sawicka J, Kaczmarek M, Slomski R. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients. Oncol Rep. 2006;16:65–71.PubMed
104.
Zurück zum Zitat Toyama T, Zhang Z, Nishio M, Hamaguchi M, Kondo N, Iwase H, et al. Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast Cancer Res. 2007;9:R34.PubMedCrossRef Toyama T, Zhang Z, Nishio M, Hamaguchi M, Kondo N, Iwase H, et al. Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast Cancer Res. 2007;9:R34.PubMedCrossRef
105.
Zurück zum Zitat Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC. Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet. 1993;53:752–9.PubMed Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC. Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet. 1993;53:752–9.PubMed
106.
Zurück zum Zitat Li X, Dumont P, Della PA, Shetler C, Murphy ME. The codon 47 polymorphism in p53 is functionally significant. J Biol Chem. 2005;280:24245–51.PubMedCrossRef Li X, Dumont P, Della PA, Shetler C, Murphy ME. The codon 47 polymorphism in p53 is functionally significant. J Biol Chem. 2005;280:24245–51.PubMedCrossRef
107.
Zurück zum Zitat Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, Bumpers H. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res. 2009;15:2406–16.PubMedCrossRef Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, Bumpers H. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res. 2009;15:2406–16.PubMedCrossRef
109.
Zurück zum Zitat Chao C, Zhang Z-F, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:979–87.CrossRef Chao C, Zhang Z-F, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:979–87.CrossRef
110.
Zurück zum Zitat Siegel D, Gustafson DL, Dehn DL, et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol. 2004;65:1238–47.PubMedCrossRef Siegel D, Gustafson DL, Dehn DL, et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol. 2004;65:1238–47.PubMedCrossRef
111.
Zurück zum Zitat Chen H, Lum A, Seifried A, Wilkens LR, Marchand LL. Association of the NAD(P)H:quinone oxidoreductase 609C3T polymorphism with a decreased lung cancer risk. Cancer Res. 1999;59:3045–8.PubMed Chen H, Lum A, Seifried A, Wilkens LR, Marchand LL. Association of the NAD(P)H:quinone oxidoreductase 609C3T polymorphism with a decreased lung cancer risk. Cancer Res. 1999;59:3045–8.PubMed
112.
Zurück zum Zitat Winski SL, Koutalos Y, Bentley DL, Ross D. Subcellular localization of NAD(P)H: quinone oxidoreductase 1 in human cancer cells. Cancer Res. 2002;62:1420–4.PubMed Winski SL, Koutalos Y, Bentley DL, Ross D. Subcellular localization of NAD(P)H: quinone oxidoreductase 1 in human cancer cells. Cancer Res. 2002;62:1420–4.PubMed
113.
Zurück zum Zitat Begleiter A, Hewitt D, Maksymiuk AW, Ross DA, Bird RP. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol Biomark Prev. 2006;15:2422–6.CrossRef Begleiter A, Hewitt D, Maksymiuk AW, Ross DA, Bird RP. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol Biomark Prev. 2006;15:2422–6.CrossRef
114.
Zurück zum Zitat Wang Y, Yang H, Li L, Wang H, Zhang C, Yin G, et al. Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis. Eur J Cancer. 2010;46:758–64.PubMedCrossRef Wang Y, Yang H, Li L, Wang H, Zhang C, Yin G, et al. Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis. Eur J Cancer. 2010;46:758–64.PubMedCrossRef
115.
Zurück zum Zitat Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991;4:168–79.PubMedCrossRef Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991;4:168–79.PubMedCrossRef
116.
Zurück zum Zitat Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology. 1993;79:795–807.PubMedCrossRef Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology. 1993;79:795–807.PubMedCrossRef
117.
Zurück zum Zitat Ulusoy G, Arinç E, Adali O. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol. 2007;81:711–8.PubMedCrossRef Ulusoy G, Arinç E, Adali O. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol. 2007;81:711–8.PubMedCrossRef
118.
Zurück zum Zitat Zhou GW, Hu J, Li Q. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis. World J Gastroenterol. 2010;16:2949–53.PubMedCrossRef Zhou GW, Hu J, Li Q. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis. World J Gastroenterol. 2010;16:2949–53.PubMedCrossRef
119.
Zurück zum Zitat Morita M, Tabata S, Tajima O, Yin G, Abe H, Kono S. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study. Cancer Epidemiol Biomark Prev. 2008;17:1800–7.CrossRef Morita M, Tabata S, Tajima O, Yin G, Abe H, Kono S. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study. Cancer Epidemiol Biomark Prev. 2008;17:1800–7.CrossRef
120.
Zurück zum Zitat Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem. 1991;110:559–65.PubMed Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem. 1991;110:559–65.PubMed
121.
Zurück zum Zitat Nomura F, Itoga S, Uchimoto T, et al. Transcriptional activity of the tandem repeat polymorphism in the 5′-flanking region of the human CYP2E1 gene. Alcohol Clin Exp Res. 2003;27:42S–6S.PubMedCrossRef Nomura F, Itoga S, Uchimoto T, et al. Transcriptional activity of the tandem repeat polymorphism in the 5′-flanking region of the human CYP2E1 gene. Alcohol Clin Exp Res. 2003;27:42S–6S.PubMedCrossRef
123.
Zurück zum Zitat Wagner C. Biochemical role of folate in cellular metabolism. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker; 1995. p. 23–42. Wagner C. Biochemical role of folate in cellular metabolism. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker; 1995. p. 23–42.
124.
Zurück zum Zitat Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–3.
125.
Zurück zum Zitat Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomark Prev. 2004;13:1331–6. Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomark Prev. 2004;13:1331–6.
126.
Zurück zum Zitat Kono S, Chen K. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci. 2005;96:535–42.PubMedCrossRef Kono S, Chen K. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci. 2005;96:535–42.PubMedCrossRef
127.
Zurück zum Zitat Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997;57:1098–102.PubMed Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997;57:1098–102.PubMed
128.
Zurück zum Zitat Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci U S A. 1998;95:13217–20129.PubMedCrossRef Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci U S A. 1998;95:13217–20129.PubMedCrossRef
129.
Zurück zum Zitat Shinmura K, Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal. 2001;3:597–609.PubMedCrossRef Shinmura K, Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal. 2001;3:597–609.PubMedCrossRef
130.
Zurück zum Zitat Kohno T, Shinmura K, Tosaka M, Tani M, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219–25.PubMedCrossRef Kohno T, Shinmura K, Tosaka M, Tani M, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219–25.PubMedCrossRef
131.
Zurück zum Zitat Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol. 2005;162:925–42.PubMedCrossRef Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol. 2005;162:925–42.PubMedCrossRef
132.
Zurück zum Zitat Nishioka K, Ohtsubo T, Oda H, Fujiwara T, et al. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell. 1999;10:1637–52.PubMed Nishioka K, Ohtsubo T, Oda H, Fujiwara T, et al. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell. 1999;10:1637–52.PubMed
133.
Zurück zum Zitat Nohmi T, Kim SR, Yamada M. Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutat Res. 2005;591:60–73.PubMedCrossRef Nohmi T, Kim SR, Yamada M. Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutat Res. 2005;591:60–73.PubMedCrossRef
134.
Zurück zum Zitat Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:409–12. Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:409–12.
135.
Zurück zum Zitat Sugimura H, Kohno T, Wakai K, Nagura K, et al. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomark Prev. 1999;8:669–74. Sugimura H, Kohno T, Wakai K, Nagura K, et al. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomark Prev. 1999;8:669–74.
136.
Zurück zum Zitat Yoshimura K, Hanaoka T, Ohnami S, Ohnami S, et al. Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples. J Hum Genet. 2003;48:654–8.PubMedCrossRef Yoshimura K, Hanaoka T, Ohnami S, Ohnami S, et al. Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples. J Hum Genet. 2003;48:654–8.PubMedCrossRef
137.
Zurück zum Zitat Yamane A, Kohno T, Ito K, Sunaga N, et al. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis. 2004;25:1689–94.PubMedCrossRef Yamane A, Kohno T, Ito K, Sunaga N, et al. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis. 2004;25:1689–94.PubMedCrossRef
138.
Zurück zum Zitat Sameer AS, Nissar S, Abdullah S, Chowdri NA, Siddiqi MA. DNA repair gene 8-oxoguanine DNA glycosylase Ser326Cys polymorphism and colorectal cancer risk in a Kashmiri population. DNA Cell Biol. 2012;31(4):541–6.PubMedCrossRef Sameer AS, Nissar S, Abdullah S, Chowdri NA, Siddiqi MA. DNA repair gene 8-oxoguanine DNA glycosylase Ser326Cys polymorphism and colorectal cancer risk in a Kashmiri population. DNA Cell Biol. 2012;31(4):541–6.PubMedCrossRef
139.
Zurück zum Zitat Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human glutathione S-transferase GSTP1–1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. Eur J Biochem. 1994;224:893–9.PubMedCrossRef Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human glutathione S-transferase GSTP1–1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. Eur J Biochem. 1994;224:893–9.PubMedCrossRef
140.
Zurück zum Zitat Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ, Wolf CR. π-class glutathione S transferase: regulation and function. Chem Biol Interact. 1998;111–112:69–82.PubMedCrossRef Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ, Wolf CR. π-class glutathione S transferase: regulation and function. Chem Biol Interact. 1998;111–112:69–82.PubMedCrossRef
141.
Zurück zum Zitat Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinog (Lond). 1997;18:1285–9.CrossRef Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinog (Lond). 1997;18:1285–9.CrossRef
142.
Zurück zum Zitat Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 1998;19:275–80.PubMedCrossRef Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 1998;19:275–80.PubMedCrossRef
143.
Zurück zum Zitat Garcia-Saèz I, Parraga A, Phillips MF, Mantle TJ, Coll M. Molecular structure at 1.8 Å of mouse liver class pi glutathione S-transferase complexed with s-(p-nitrobenzyl)glutathione and other inhibitors. J Mol Biol. 1994;237:298–314.PubMedCrossRef Garcia-Saèz I, Parraga A, Phillips MF, Mantle TJ, Coll M. Molecular structure at 1.8 Å of mouse liver class pi glutathione S-transferase complexed with s-(p-nitrobenzyl)glutathione and other inhibitors. J Mol Biol. 1994;237:298–314.PubMedCrossRef
144.
Zurück zum Zitat Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst. 2002;94(12):936–42.PubMedCrossRef Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst. 2002;94(12):936–42.PubMedCrossRef
145.
Zurück zum Zitat Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC. Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J Gastroenterol. 2005;11(10):1473–80.PubMed Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC. Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J Gastroenterol. 2005;11(10):1473–80.PubMed
146.
Zurück zum Zitat Board PG, Baker RT, Chelvanayagam G, Jermiin LS. Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J. 1997;328:929–35.PubMed Board PG, Baker RT, Chelvanayagam G, Jermiin LS. Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J. 1997;328:929–35.PubMed
147.
Zurück zum Zitat Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O’Brien EE, et al. Expression of anionic glutathione S transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989;49:1422–8.PubMed Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O’Brien EE, et al. Expression of anionic glutathione S transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989;49:1422–8.PubMed
148.
Zurück zum Zitat Sameer AS, Qadri A, Siddiqi MA. GSTP1 I105V polymorphism and susceptibility to colorectal cancer in Kashmiri population. DNA Cell Biol. 2012;31(1):74–9.PubMedCrossRef Sameer AS, Qadri A, Siddiqi MA. GSTP1 I105V polymorphism and susceptibility to colorectal cancer in Kashmiri population. DNA Cell Biol. 2012;31(1):74–9.PubMedCrossRef
149.
Zurück zum Zitat Yu Z, Chen J, Ford BN, Brackley ME, Glickman BW. Human DNA repair systems: an overview. Environ Mol Mutagen. 1999;33:3–20.PubMedCrossRef Yu Z, Chen J, Ford BN, Brackley ME, Glickman BW. Human DNA repair systems: an overview. Environ Mol Mutagen. 1999;33:3–20.PubMedCrossRef
150.
Zurück zum Zitat Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science. 2001;291:1284–9.PubMedCrossRef Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science. 2001;291:1284–9.PubMedCrossRef
151.
Zurück zum Zitat Caldecott KW, Aoufouchi S, Johnson P, Shall S. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular ‘nick-sensor’ in vitro. Nucleic Acids Res. 1996;24:4387–94.PubMedCrossRef Caldecott KW, Aoufouchi S, Johnson P, Shall S. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular ‘nick-sensor’ in vitro. Nucleic Acids Res. 1996;24:4387–94.PubMedCrossRef
152.
Zurück zum Zitat Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593–600.PubMed Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593–600.PubMed
153.
Zurück zum Zitat Marintchev A, Mullen MA, Maciejewski MW, Pan B, Gryk MR, Mullen GP. Solution structure of the single-strand break repair protein XRCC1 N-terminal domain. Nat Struct Biol. 1999;6:884–93.PubMedCrossRef Marintchev A, Mullen MA, Maciejewski MW, Pan B, Gryk MR, Mullen GP. Solution structure of the single-strand break repair protein XRCC1 N-terminal domain. Nat Struct Biol. 1999;6:884–93.PubMedCrossRef
154.
Zurück zum Zitat Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604–8.PubMed Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604–8.PubMed
155.
Zurück zum Zitat Abdel-Rahman SZ, Soliman AS, Bondy ML, Omar S, El-Badawy SA, Khaled HM, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett. 2000;159:79–86.PubMedCrossRef Abdel-Rahman SZ, Soliman AS, Bondy ML, Omar S, El-Badawy SA, Khaled HM, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett. 2000;159:79–86.PubMedCrossRef
156.
Zurück zum Zitat Wang J, Zhao Y, Jiang J, Gajalakshmi V, Kuriki K, Nakamura S, et al. Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case–control study in an Indian population. J Cancer Res Clin Oncol. 2010;136:1517–25.PubMedCrossRef Wang J, Zhao Y, Jiang J, Gajalakshmi V, Kuriki K, Nakamura S, et al. Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case–control study in an Indian population. J Cancer Res Clin Oncol. 2010;136:1517–25.PubMedCrossRef
157.
Zurück zum Zitat Sameer AS, Nissar S, Lone TA, Banday MZ, Parray FQ, Chowdri NA, Rasool R, Abdullah S. XRCC1 Arg 399 Gln polymorphism and risk of colorectal cancer: a case control study in Kashmiri population. 2013;5:959–963. Sameer AS, Nissar S, Lone TA, Banday MZ, Parray FQ, Chowdri NA, Rasool R, Abdullah S. XRCC1 Arg 399 Gln polymorphism and risk of colorectal cancer: a case control study in Kashmiri population. 2013;5:959–963.
Metadaten
Titel
Colorectal cancer: a researcher’s perspective of the molecular angel’s gone eccentric in the Vale of Kashmir
verfasst von
Aga Syed Sameer
Publikationsdatum
01.06.2013
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 3/2013
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0692-4

Weitere Artikel der Ausgabe 3/2013

Tumor Biology 3/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.